0114 232 9292 connect@medilink.co.uk

Medilink member TissuePatch to launch product range at Chinese Neuro Meeting

Following the recent approval of TissuePatch™ in China, Tissuemed is pleased to announce that the company will be attending the forthcoming meeting of the Chinese Neurosurgical Society, held in Lanzhou on 8-10 September.

Tissuemed CEO, Dr David Mandley commented: “With more than 3,000 delegatissuemedtes expected to participate from across China, this is an excellent opportunity for Tissuemed®, in collaboration with our local partners, to launch the TissuePatch™ range to the Chinese neurosurgical community. We look forward to engaging with surgeons and demonstrating how TissuePatch™ can be used for dural closure to seal and reinforce, so CSF leaks are prevented and post-operative complications eliminated."

For more information on TissuePatch for dural sealing, click here

Comments are closed.